Nutrition and Neuroprotection in Aging: A Review of Omega-3, Flavonoids, B-Vitamins, MCT Oil, and Ketogenic Protocols for Dementia Prevention
DOI:
https://doi.org/10.30872/jtpc.v9i2.309Keywords:
dementia prevention, omega-3 fatty acids, flavonoids, B-vitamins, ketogenic dietAbstract
Population aging has led to a global increase in dementia, particularly Alzheimer’s disease and vascular dementia. Diet is a key modifiable factor with growing potential for neuroprotection. This review synthesizes mechanistic, epidemiological, and clinical evidence on five nutritional strategies relevant to dementia prevention: omega-3 polyunsaturated fatty acids (PUFAs), flavonoids, B-vitamins, medium-chain triglyceride (MCT) oil, and ketogenic approaches. A narrative review with systematic search elements was conducted using PubMed, Web of Science, and Scopus, prioritizing meta-analyses, large prospective cohorts, and randomized controlled trials involving older adults, mild cognitive impairment (MCI), and dementia. Evidence indicates that higher intake or status of omega-3 PUFAs and flavonoid-rich foods is associated with reduced dementia risk and modest cognitive benefits, particularly in midlife or prodromal stages. B-vitamin supplementation may slow brain atrophy and cognitive decline in individuals with elevated homocysteine, while effects are limited in unselected populations. MCT oil and ketogenic interventions improve cognition by providing alternative brain energy substrates, with greater benefits observed in MCI and APOE ε4 non-carriers. Overall, a multi-target nutritional approach addressing neuroinflammation, vascular health, homocysteine metabolism, and brain energy deficits shows promise for dementia prevention. Future research should emphasize biomarker-guided personalization and integration with broader lifestyle interventions.
Downloads
References
1. Bao-Zhen, W., Li, L., Dong, C.-W., Tan, C.-C., & Xu, W. (2023). The relationship of omega-3 fatty acids with dementia and cognitive decline: Evidence from prospective cohort studies of supplementation, dietary intake, and blood markers. American Journal of Clinical Nutrition, 117(6), 1096–1109. https://doi.org/10.1016/j.ajcnut.2023.04.001
2. Boudrault, C., Bazinet, R. P., & Ma, D. W. L. (2009). Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer’s disease. Journal of Nutritional Biochemistry, 20(1), 1–10. https://doi.org/10.1016/j.jnutbio.2008.05.016
3. Cheng, N., Bell, L., Lamport, D. J., & Williams, C. M. (2022). Dietary flavonoids and human cognition: A meta-analysis. Molecular Nutrition & Food Research, 66(21), e2100976. https://doi.org/10.1002/mnfr.202100976
4. Clarke, R. (2007). Homocysteine, B vitamins, and the risk of dementia. American Journal of Clinical Nutrition, 85(2), 329–330. https://doi.org/10.1093/ajcn/85.2.329
5. Clarke, R., Bennett, D., Parish, S., Lewington, S., Skeaff, M., Eussen, S. J. P. M., Lewerin, C., Stott, D. J., Armitage, J., Hankey, G. J., Lonn, E., Spence, J. D., Galan, P., de Groot, L. C. P. G. M., Halsey, J., Dangour, A. D., & Collins, R. (2014). Effects of homocysteine lowering with B vitamins on cognitive aging: Meta-analysis of 11 trials with cognitive data on 22,000 individuals. American Journal of Clinical Nutrition, 100(2), 657–666. https://doi.org/10.3945/ajcn.113.076349
6. Cole, G. M., Ma, Q.-L., & Frautschy, S. A. (2009). Omega-3 fatty acids and dementia. Prostaglandins, Leukotrienes and Essential Fatty Acids, 81(2–3), 213–221. https://doi.org/10.1016/j.plefa.2009.05.015
7. Fortier, M., Castellano, C.-A., Croteau, E., Langlois, F., Bocti, C., St-Pierre, V., Vandal, M., Bernard, A., & Cunnane, S. C. (2020). A ketogenic drink improves cognition in mild cognitive impairment: Results of a 6-month RCT. Alzheimer’s & Dementia, 16(S6), e043882. https://doi.org/10.1002/alz.12206
8. Henderson, S. T., Vogel, J. L., Barr, L. J., Garvin, F., Jones, J. J., & Costantini, L. C. (2009). Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer’s disease: A randomized, double-blind, placebo-controlled, multicenter trial. Nutrition & Metabolism, 6, 31. https://doi.org/10.1186/1743-7075-6-31
9. Heras-Sandoval, D., Pedraza-Chaverri, J., & Pérez-Rojas, J. M. (2016). Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer’s disease. Journal of Neuroinflammation, 13, 61. https://doi.org/10.1186/s12974-016-0525-7
10. Jennings, A., Thompson, A. S., Tresserra-Rimbau, A., O’Neill, J. K., Hill, C., Bondonno, N. P., Kühn, T., & Cassidy, A. (2024). Flavonoid-rich foods, dementia risk, and interactions with genetic risk, hypertension, and depression. JAMA Network Open, 7(9), e2434136. https://doi.org/10.1001/jamanetworkopen.2024.34136
11. Lyu, C., Kiely, M., Jacques, P. F., Zhang, X., McManus, D. D., & Gao, X. (2024). Flavonoid-rich fruit intake in midlife and late life and associations with risk of dementia: The Framingham Heart Study. Nutrients, 16(11), 2381. https://doi.org/10.3390/nu16112381
12. Mentzelou, M., Tsoukalas, D., Anastasiou, E., Tsioufis, K., & Sidossis, L. S. (2023). Ketogenic diet and cognitive function: A scoping review from basic research to clinical practice. Nutrients, 15(10), 2270. https://doi.org/10.3390/nu15102270
13. Nagpal, R., Neth, B. J., Wang, S., Craft, S., & Yadav, H. (2019). Modified Mediterranean–ketogenic diet modulates the gut microbiome and short-chain fatty acids in association with Alzheimer’s disease markers in subjects with mild cognitive impairment. EBioMedicine, 47, 529–542. https://doi.org/10.1016/j.ebiom.2019.08.032
14. Phillips, M. C. L., Deprez, L. M., Mortimer, G. M. N., Murtagh, D. K. J., McCoy, S., McManus, E. J., Clark, K. M., Gilbertson, L. J., Simpson, P. V., & Cervenka, M. C. (2021). Randomized crossover trial of a modified ketogenic diet in Alzheimer’s disease. Alzheimer’s Research & Therapy, 13, 51. https://doi.org/10.1186/s13195-021-00783-x
15. Smith, A. D., Refsum, H., & Bottiglieri, T. (2016). Homocysteine, B vitamins, and cognitive impairment. Annual Review of Nutrition, 36, 211–239. https://doi.org/10.1146/annurev-nutr-071715-050947
16. Song, Y., LaMonica, H. M., Jackson, J., et al. (2024). Mid-life adherence to the Dietary Approaches to Stop Hypertension (DASH) and MIND diets and the risk of dementia: An analysis of the UK Biobank. Alzheimer’s & Dementia, 20(3), 976–988. https://doi.org/10.1002/alz.13468
17. Vauzour, D., Camprubi-Robles, M., Miquel-Kergoat, S., Andres-Lacueva, C., Bánáti, D., Barberger-Gateau, P., Bowman, G. L., Caberlotto, L., Clarke, R., Hogervorst, E., et al. (2017). Nutrition for the ageing brain: Towards evidence for an optimal diet. Ageing Research Reviews, 35, 222–240. https://doi.org/10.1016/j.arr.2016.09.010
18. Yeh, T.-S., Yuan, C., Ascherio, A., Rosner, B. A., Willett, W. C., & Blacker, D. (2021). Long-term dietary flavonoid intake and subjective cognitive decline in US men and women. Neurology, 97(10), e1041–e1056. https://doi.org/10.1212/WNL.0000000000012454
19. Zhao, Z., Wang, C., Zhang, Y., & Zhang, J. (2023). The association between dietary intake of flavonoids and cognitive function in older adults: A cross-sectional study. Frontiers in Nutrition, 10, 1195107. https://doi.org/10.3389/fnut.2023.1195107
20. Zimmermann, H. R., Song, Y., Pan, A., & Hu, F. B. (2021). Plant foods rich in antioxidants and human cognition: A systematic review. Antioxidants, 10(5), 714. https://doi.org/10.3390/antiox10050714
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Ignatius Danny Pattirajawane (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

